Synthomer is a specialty chemicals company that produces high-performance, highly specialized polymers and ingredients. The company operates through three divisions serving end markets including adhesives, coatings, construction, health and protection, consumer materials, performance materials, energy solutions, and paper, carpet, and foam. Synthomer supplies water-based polymers to business customers in the EMEA, Asia Pacific, and Americas regions. The company maintains innovation centers in the UK, Germany, Malaysia, China, and the USA, alongside manufacturing sites across Europe, the Americas, and Asia. Its history dates back to 1863. Synthomer is divesting its Acrylate Monomers business, operated by Synthomer a.s., to Mutares SE & Co. KGaA.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Specialty Chemicals Homepage synthomer.com
Sector Basic Materials IR page synthomer.com/investor-relations
Tags
polymers, adhesives, coatings, construction chemicals, health and protection, energy solutions, water-based polymers, specialty chemicals, Synthomer a.s.
Press page —

Metrics

Valuation  
Market cap £ 80.414M
Market cap (USD) $ 106.593M
P/E -0.51
PEG —
P/BV 0.09
P/S 0.05
P/OCF 0.65
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE -15.5%
ROI -9.3%
ROIC -2.2%
Profit margin -9.0%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 83.6%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -56.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Revenue 1.739B 1.987B 1.941B 2.384B 2.33B 1.644B 1.459B 1.619B 1.48B 1.046B — 936.4M 992.7M 1.053B 1.059B 5.689M 527.948M
Net profit -156.9M -69.3M -66.8M -33M 210M -1.5M 85.6M 3.5M 105.3M 97.7M — 67.6M 72.9M -18.5M -30.4M 17.324M 33.276M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Share price 0.49 1.16 1.87 1.02 3.96 4.65 — — — — — — — — — — —
Price performance 12m -0.58 -0.38 0.83 -0.74 -0.15 — — — — — — — — — — — —

Filed figures

Figure Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (GBP) 262M 313M 272M 213M 227M 154M
↳ YoY growth +19.2% -13.2% -21.6% +6.7% -32.3%
↳ 5y CAGR -10.1%
Borrowings, current (GBP) 20.1M 0.00 18.5M 700,000 124M 0.00
Borrowings, non-current (GBP) 644M 620M 1.23B 870M 699M 765M
Lease liabilities (GBP) 55M 43.5M 45.5M 55.3M 55.9M 53.6M
Cash and deposits (GBP) 202M 505M 228M 371M 226M 190M
Net debt (borrowings + leases - cash) (GBP) 517M 158M 1.07B 555M 653M 629M
Cash flow detail
Operating cash flow (GBP) 187M 274M 134M 150M -33.5M 124M
Purchases of property, plant and equipment (GBP) -53.8M -82.2M -90.8M -84M -90.6M -87.7M
Dividends paid (cash effect) (GBP) -12.8M -73.5M -99.5M 0.00 0.00 -2.1M
Share buybacks (cash effect) (GBP) -200,000 -900,000 -1.5M -400,000 -200,000 0.00
Interest paid (cash effect) (GBP) -13.6M -27.1M -38.4M -62.7M -64.3M -62.3M
Income taxes paid (cash effect) (GBP) -31.4M -86.4M -65.6M 9.3M -18.1M 500,000
Free cash flow (OCF - PPE - intangibles) (GBP) 133M 191M 43.1M 66M -124M 36.6M
Income detail
Total comprehensive income (GBP) -28.3M 275M 98.3M -131M -55.3M -194M
Reported Mar 29, 2022 Mar 29, 2022 Apr 13, 2023 Mar 25, 2025 Mar 25, 2025 Apr 30, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Trading statement - Autumn 2026 Bull 2 Bear 0 Guidance

| X WhatsApp Email LinkedIn Facebook WeChat Print Share | Close |

RNS Number : 9486Z

Synthomer PLC

22 October 2026

Synthomer plc Autumn 2026 trading statement

Q3 in line with expectations, continued strategic and operational momentum FY outlook reaffirmed

Synthomer plc ('Synthomer' or the 'Group') today issues a scheduled update on trading for the third quarter of 2026.

• Q3 performance in line with previously upgraded expectations for the full year, with volume, revenue and substantial EBITDA growth continuing

• Strategic and operational initiatives driving ongoing momentum through product innovation, US / China growth and cost efficiency actions

• Divestment processes progressing to enhance strategic focus and reduce debt

• Confident in delivery of our full year 2026 outlook and sustained progress in 2027

Overall, the Group delivered ongoing improvement in Continuing Group volume, revenue and EBITDA in Q3 2026 vs Q3 2025, consistent with our upgraded expectations for the full year as set out in the interim results. Progress in the period was driven by strategic and operational momentum in the Coatings & Construction Solutions (CCS) and Adhesive Solutions (AS) divisions from new product and innovation growth initiatives and targeted regional growth in the USA and China, as well as delivery of further cost efficiencies across the Group.

Growth from innovative products or adjacent applications including in AI data centre construction, onshore oil and gas drilling and medical continued in the period. Ongoing disruption to petrochemical supply chains from the Middle East has meant that raw material costs have remained elevated, although the significant availability issues within competitor supply chains in Asia, which benefited primarily Health & Protection during Q2, have moderated with the relative net benefit to the Group more limited in the period.

We demonstrate pricing power by delivering robust pass through of higher raw material costs across the Group, reflecting the importance of our differentiated speciality products to our customers and the increasing value ascribed to our agile, 'in region for region' manufacturing and world-class procurement capabilities. In addition, we have maintained our rigorous focus on cost management. This is evident in the progression in year to date margins in all three divisions and enhances the Group's operational gearing benefits from further top line growth.

In summary, we remain confident of delivering our full year 2026 outlook, reflecting the strong EBITDA outturn in the first half and our expectations of ongoing strategic growth and cost efficiency progress through the remainder of the year. As the benefits of our strategic initiatives continue to compound we expect to sustain our positive momentum in 2027.

We also remain very focused on cash generation and expect to deliver positive free cash flow before non-recourse receivables financing movements for the full year. With leverage at the end of September reduced as expected compared with the end of June, we continue to expect an improvement in covenant net debt: EBITDA to 4.0-4.35x (excluding further divestments) by the end of 2026, providing significant covenant headroom.

Alongside operational execution, we are making progress with the strategic transformation of the Group towards more differentiated speciality businesses and the structural improvement of our balance sheet. The divestment of the Acrylate Monomers business based in the Czech Republic was completed on 30 September as planned, removing a cyclical and capital-intensive base chemicals business from the Group, improving profitability and cash generation, and further transitioning the simplified portfolio towards a speciality focus. We continue to make good progress on our other divestment projects.

Commenting, Synthomer CEO Michael Willome said:

"Synthomer continues to deliver strong strategic and operational momentum as we increase the focus towards our differentiated speciality business and by 'controlling the controllables'. This includes innovating to develop higher margin products and reach new markets, growing in the USA and China, and supporting customer-led sustainability developments. At the same time, we remain focused on optimising our regional manufacturing strategy and delivering further cost and complexity reductions. The geopolitical and market environment remains volatile, but we are confident that by executing our speciality strategy we will drive earnings growth and improved free cash flow over the remainder of 2026, with significant opportunity and sustained momentum in 2027."

Further information:

| Investors: Faisal Tabbah, Vice President Investor Relations | Tel: +44 (0) 1279 775 306 |

| Media: Tom Climie / Guy Bates, Kekst CNC | Tel: +44 (0) 7760 160 248 / +44 (0) 7581 056 415 |

Notes

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection - growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed there since 1971, we employ c.3,500 employees across our five innovation centres of excellence and 28 manufacturing sites across Europe, North America, Middle East and Asia. With more than 6,000 blue-chip customers and £1.7bn in continuing revenue in 2025, our business is built around three divisions, serving customers in attractive end markets where demand is driven by global megatrends including urbanisation, demographic change, climate change and sustainability, and shifting economic power.

In Coatings & Construction Solutions, our specialist polymers enhance the sustainability and performance of a wide range of coatings and construction products. We serve customers in applications including architectural and masonry coatings, mortar modification, waterproofing and flooring, fibre bonding, and energy solutions. In Adhesive Solutions our products help our customers bond, modify and compatibilise surfaces and components for applications including tapes and labels, packaging, hygiene, tyres and plastic modification, improving permeability, strength, elasticity, damping, dispersion and grip. In Health & Protection and Performance Materials we are a world-leading supplier of water-based polymers for medical gloves, and a major European manufacturer of high-performance binders, foams and other products serving customers in a range of end markets.

Our purpose is creating innovative and sustainable solutions for the benefit of customers and society. Around 20% of our sales volumes are from new and patent protected products. At our innovation centres of excellence in the UK, China, Germany, Malaysia and Ohio, USA we collaborate closely with our customers to develop new products and enhance existing ones tailored to their needs, with an increasing range of sustainability benefits. Our 2030 decarbonisation targets have been approved by the Science Based Targets initiative as being in line with what the latest climate science says is necessary to meet the goals of the Paris Agreement, and since 2021 we have held the London Stock Exchange Green Economy Mark, which recognises green technology businesses making a significant contribution to a more sustainable, low-carbon economy. Find us at www.synthomer.com or search for Synthomer on LinkedIn.

Legal Entity Identifier (LEI): 213800EHT3TI1KPQQJ56.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTFLFFDIRLLFIR

Supplied by © Euroland.Com

Terms of Service

✓

Thanks for sharing!

AddToAny

More…

Holding(s) in Company Bull 0 Bear 0 Routine

| X WhatsApp Email LinkedIn Facebook WeChat Print Share | Close |

RNS Number : 6941Z

Synthomer PLC

20 October 2026

TR-1: Standard form for notification of major holdings

  1. Issuer Details

ISIN

GB00BNTVWJ75

Issuer Name

SYNTHOMER PLC

UK or Non-UK Issuer

UK

  1. Reason for Notification

An acquisition or disposal of voting rights

  1. Details of person subject to the notification obligation

Name

Greater Manchester Pension Fund

City of registered office (if applicable)

Manchester

Country of registered office (if applicable)

United Kingdom

  1. Details of the shareholder

| Name | City of registered office | Country of registered office |

| Nortrust Noms Ltd | | |

  1. Date on which the threshold was crossed or reached

14-Oct-2026

  1. Date on which Issuer notified

16-Oct-2026

  1. Total positions of person(s) subject to the notification obligation

| | % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer |

| Resulting situation on the date on which threshold was crossed or reached | 3.990000 | 0.000000 | 3.990000 | 6542939 |

| Position of previous notification (if applicable) | 4.820000 | 0.000000 | 4.820000 | |

  1. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |

| GB00BNTVWJ5 | 6542939 | | 3.990000 | |

| Sub Total 8.A | 6542939 | 3.990000% |

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

| Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |

| | | | | |

| Sub Total 8.B1 | | | |

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

| Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |

| | | | | | |

| Sub Total 8.B2 | | | |

  1. Information in relation to the person subject to the notification obligation

  2. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

| Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |

| | | | | |

  1. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

If date does not apply, explain below

  1. Additional Information

The fund manager for this asset is: UBS Asset Management

  1. Date of Completion

16-Oct-2026

  1. Place Of Completion

Tameside, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLFIFLAIVLIFIR

Supplied by © Euroland.Com

Terms of Service

✓

Thanks for sharing!

AddToAny

More…

Director Declaration Bull 0 Bear 0 Routine

| X WhatsApp Email LinkedIn Facebook WeChat Print Share | Close |

RNS Number : 4764X

Synthomer PLC

02 October 2026

Synthomer plc Directorate Declaration

Synthomer plc announces that Dato' Lee Hau Hian, Non-Independent Non-Executive Director of the Company, was appointed as a Non-Independent Non-Executive Director of MKH Oil Palm (East Kalimantan) Berhad, a company listed on Bursa Malaysia.

This disclosure is made in accordance with UKLR 6.4.9R(2).

Further information:

Anant Prakash, Company Secretary Tel: +44 (0) 1279 774 328

Legal Entity Identifier (LEI): 213800EHT3TI1KPQQJ56.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNFSMFLEEMSESS

Supplied by © Euroland.Com

Terms of Service

✓

Thanks for sharing!

AddToAny

More…

Prompts

Synthomer plc (ticker SYNT), listed in United Kingdom.

ETFs Holding Synthomer plc

ETF Weight in ETF Shares Market value As of
AVDV 0.01% 1,451,896 $ 2.279M Nov 16, 2026
AVDS 0.01% 13,309 $ 20.895K Nov 16, 2026
DFIS 0.00% 29,889 $ 45.263K Nov 12, 2026
AVDE 0.00% 160,036 $ 251.257K Nov 16, 2026
AVSD 0.00% 1,328 $ 2,084.97 Nov 16, 2026